Sempere A, Assoumou L, Gonzalez-Cordon A, Waters L, et al. Incidence of hypertension and blood pressure changes in persons with HIV at high risk for cardiovascular disease switching from boosted protease inhibitors to dolutegravir: a post-hoc analysis of the 96-week randomised NEAT-022 trial. Clin Infect Dis 2023 May 19:ciad297. doi: 10.1093.
PMID: 37207617